Renal-AKI and CKD Flashcards

AKI and AoCKD

1
Q

What is the definition of Acute Kidney Injury (AKI)?

A

AKI is a sudden decline in kidney function characterized by an increase in serum creatinine, a decrease in urine output, or both, occurring over hours to days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the causes of prerenal AKI?

A

Prerenal AKI is caused by decreased renal perfusion, including:

Hypovolemia (e.g., hemorrhage, dehydration, vomiting, diarrhea)
Low cardiac output (e.g., heart failure, cardiogenic shock)
Systemic vasodilation (e.g., sepsis, anaphylaxis)
Renal vasoconstriction (e.g., NSAIDs, ACE inhibitors, hepatorenal syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does prerenal AKI present clinically?

A

Oliguria (low urine output)
Signs of volume depletion (e.g., dry mucous membranes, hypotension, tachycardia)
BUN:Creatinine ratio > 20:1
Low FeNa (<1%) and high urine osmolality (>500 mOsm/kg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the causes of intrinsic AKI?

A

Intrinsic AKI is caused by direct kidney damage, including:

Acute tubular necrosis (ATN) (ischemia, nephrotoxins like aminoglycosides, contrast)
Glomerulonephritis (e.g., post-streptococcal, lupus nephritis)
Acute interstitial nephritis (AIN) (drugs like NSAIDs, PPIs, infections)
Vascular causes (thrombotic microangiopathy, malignant hypertension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does intrinsic AKI present clinically?

A

Variable urine output
BUN:Creatinine ratio ~10-15:1
ATN: Muddy brown casts in urine, FeNa >2%
AIN: Eosinophilia, WBC casts, recent drug exposure
Glomerulonephritis: Hematuria, RBC casts, proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the causes of postrenal AKI?

A

Postrenal AKI results from urinary tract obstruction, including:

Prostate hypertrophy or cancer
Kidney stones (urolithiasis)
Ureteral obstruction (e.g., malignancy, fibrosis)
Neurogenic bladder (e.g., spinal cord injury)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How does postrenal AKI present clinically?

A

Fluctuating urine output (oliguria or anuria)
Suprapubic pain or distended bladder
Hydronephrosis on ultrasound
BUN:Creatinine ratio ~10-15:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the key diagnostic tests for AKI?

A
  • Serum creatinine & BUN (to assess kidney function)
  • Urinalysis (casts, protein, WBCs, RBCs)
  • Urine sodium & FeNa (distinguish prerenal vs intrinsic)
  • Renal ultrasound (hydronephrosis for postrenal causes)
  • Serological tests (autoimmune markers for glomerulonephritis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is AKI managed?

A
  • Prerenal AKI: Restore volume (IV fluids), treat underlying cause
  • Intrinsic AKI: Stop nephrotoxins, manage underlying disease (e.g., steroids for AIN)
  • Postrenal AKI: Relieve obstruction (e.g., catheterization, surgery)
    Dialysis if severe (AEIOU: Acidosis, Electrolytes, Intoxication, Overload, Uremia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the major causes of CKD?

A
  • Diabetes mellitus (most common cause)
  • Hypertension
  • Glomerulonephritis (e.g., IgA nephropathy, lupus nephritis)
  • Polycystic kidney disease (PKD)
  • Chronic infections (e.g., HIV, hepatitis B/C)
  • Obstructive nephropathy (e.g., kidney stones, BPH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the pathophysiological mechanisms of CKD?

A
  • Nephron loss → Remaining nephrons compensate, leading to hyperfiltration
  • Glomerular hypertension → Further nephron damage
  • Fibrosis & scarring → Progressive loss of kidney function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical features of CKD?

A

Early stages: Often asymptomatic

Late stages:
Fatigue, weakness
Edema (peripheral, pulmonary)
Hypertension
Anemia (↓ erythropoietin)
Uremic symptoms (pruritus, nausea, metallic taste)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the complications of CKD?

A

Cardiovascular disease (leading cause of death)
A WET BED-
Anemia
Water
Electrolytes
Toxin
BP
Erythropoietin
D (vitamin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the diagnostic tests for CKD?

A

one of the following for >3months
- Serum creatinine & GFR (assess kidney function)
- albumin-to-creatinine ratio (UACR->=30mg/g)
- Electrolytes (hyperkalemia, metabolic acidosis)
- Renal ultrasound (small, shrunken kidneys in CKD)
- Urine sediment abnormalities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the treatment goals for CKD?

A

Kidney protection:
1. Control blood pressure (target <130/80 mmHg)
2. ACE inhibitors/ARBs (protect kidneys)
3. Manage diabetes
4. Dietary modifications (↓ sodium, protein, phosphorus, potassium)
5. Use of SGLT2-I
6. Lifestyle - smoking cessation, weight loss and exercise (HbA1c target ~7%)
Symptom management:
1. Correct electrolyte imbalances
2. Treat anemia (EPO-stimulating agents, iron supplements)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When is dialysis indicated in CKD?

A

Dialysis is needed in End-Stage Renal Disease (ESRD) or when symptoms appear. Indications:
AEIOU criteria (despite medical therapy):

Acidosis (severe metabolic acidosis)
Electrolyte imbalance (severe hyperkalemia)
Intoxications (e.g., lithium, methanol)
Overload (fluid overload unresponsive to diuretics)
Uremia (encephalopathy, pericarditis)

  • Urea >100 mg/dL
  • S K >6 mmol/L
  • S HCO3 <12 mmol/L or
  • pH <7.15
  • PaO2/FiO2 <200
  • CXR with APO
    (despite medical therapy)
17
Q

How would you stage AKI?

A

Stage 1: SCr increase >=26.5mmol/L or 1.5-1.9x baseline SCr. UOP<0.5ml/kg/hour for 6-12hours

Stage 2: 2-2.9x SCr. UOP<0.5ml/kg/hr for >=12hours

Stage 3: SCr>=3x SCr or increase SCr to >=354mml/L or HD initiation. UOP<0.3ml/kg/hour >=24hours or anuria >=12hours

18
Q

What are the causes of intrinsic AKI?

A

Acute tubular injury
(eg. prolonged pre-renal AKI, rhabdomyolysis, hemoglobinuria, nephrotoxins)
Tubulointerstitial injury
GN, Myeloma, vasculitis (Lupus, ANCA associated)

19
Q

What is the formula to calculate frusemide quantity for stress test

A

IV Furosemide 1 mg/kg or
1.5 mg/kg if history of
furosemide in past 7 days

20
Q

What is considered Frusemide Stress test responsive

A

UO >200 mL in 2 hours

21
Q

Functional staging of CKD based on GFR

A

G1 >=90
G2 60-89
G3a 45-59
G3b 30-44
G4 15-29
G5 <15

22
Q

Albuminuria categories in CKD

A

A1 AER<30mg/24hrs, ACR<30mg/g
A2 AER 30-300mg/24hrs, ACR 30-300mg/g
A3 AER>300mg/24hrs, ACR >300mg/g

23
Q

What medicine to avoid if critically sick or unable to maintain adequate hydration?

A

– S - sulfonylureas
– A - ACE-inhibitors
– D - diuretics
– M -metformin
– A - ARB
– N - NSAIDs / Cox-2 inhibitors
– S – SGLT-2 inhibitor

24
Q

For renal patients, how do you work up anemia?

A
  1. Hb
  2. If Hb low, Fe study (transferrin sat and ferritin)
    Absolute iron deficiency when TSAT <=20%, Ferritin <=100ng/ml (CKD/PD) or <=200ng/ml (HD)
    Functional iron deficiency when TSAT <=20%, ferritin much higher (as high as 800ng/ml)
25
How to manage anemia in CKD?
Consider aiming for Hb 10 - 11.5 g/dL to avoid symptoms and complications due to anemia * Hb >11.5g/dL should be avoided as it may cause more adverse effect than benefit * Caution in giving ESA to patient with active or history of malignancy or history of stroke * Watch for adverse event of hypertension and headache
26
How to manage BMD in CKD?
* CKD 3a-5D - lower elevated phosphate toward normal range. (2C) * CKD 3a-5ND – optimal PTH level unknown. (2C)– for progressively rising or persistently elevated iPTH, to evaluate for hyperphosphatemia, hypocalcemia, high phosphate intake, and vitamin D deficiency. (2C) * CKD 3a-5ND– calcitriol and vitamin D analogs not be routinely used (2C). – reserve their use for CKD 4–5ND with severe and progressive hyperparathyroidism (Not Graded) * CKD G5D -maintain iPTH levels in the range of 2-9x the upper normal limit (2C) * 25(OH)D level – Might be measured and have repeated testing (2C)– Vitamin D deficiency and insufficiency be corrected using treatment strategies recommended for the general population (2C) target (20-40 ng/ml)
27
Managing hyperK in CKD
* Low dietary K+ intake, stop any K+ supplement and K+ sparing diuretic * Stop or switch from nonselective (e.g., carvedilol) to selective β1-receptor blockers (e.g., atenolol, bisoprolol) * Consider initiating thiazide diuretic or loop diuretics (if overloaded) * Consider sodium bicarbonate (if presence of metabolic acidosis) * Consider GI cation exchangers (e.g., sodium polystyrene sulfonate, sodium zirconium cyclosilicate, patiromer) * Stop or reduce ACEi / ARB if K+ ≥ 5.5mmol/L persistently despite above
28
How to manage acidosis in CKD?
Approximate time of worsening acidosis in CKD is when eGFR <30ml/min/1.73m2 * Range across NAGMA and/or HAGMA * Generally sodium bicarbonate tablets started when HCO3- <20mmol/L * Aim for the normal range of HCO3- 22-26mmol/L using the smallest dose of sodium bicarbonate * Start PO NaHCO3 1-2g/day, max ~4.5g/day – must monitor 63 * Monitor fluid status, serum potassium and calcium trends
29